| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/04/2023 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 210.2k | $0.24 | $50.5k | | 10/04/2023 |
| 09/30/2023 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 624.569 | $58.04 | $36.2k | | 09/30/2023 |
| 06/30/2023 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 553.943 | $63.95 | $35.4k | | 06/30/2023 |
| 03/31/2023 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 486.943 | $69.31 | $33.8k | | 03/31/2023 |
| 03/29/2023 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 41.1k | $1.05 | $43.1k | | 03/29/2023 |
| 02/01/2023 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 2.8k | $71.23 | $200k | | 02/01/2023 |
| 12/31/2022 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 469.076 | $71.95 | $33.8k | | 12/31/2022 |
| 10/05/2022 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 42.2k | $1.25 | $52.8k | | 10/05/2022 |
| 09/30/2022 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 474.75 | $71.09 | $33.7k | | 09/30/2022 |
| 08/11/2022 | Outlook Therapeutics, Inc. | ONS | Grant | Stock Option (Right to Buy) | 25k | $1.15 | $28.8k | | 08/11/2022 |
| 06/30/2022 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 438.312 | $77.00 | $33.8k | | 06/30/2022 |
| 06/16/2022 | EYENOVIA, INC. | EYEN | Grant | Common Stock, par value $.0001 | 22.2k | $0.00 | $0 | | 06/16/2022 |
| 06/16/2022 | EYENOVIA, INC. | EYEN | Grant | Stock Option (right to buy) | 30.8k | $1.80 | $55.4k | | 06/16/2022 |
| 06/03/2022 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 2.9k | $0.00 | $0 | | 06/03/2022 |
| 03/31/2022 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 462.139 | $73.03 | $33.8k | | 03/31/2022 |
| 12/31/2021 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 521.251 | $62.35 | $32.5k | | 12/31/2021 |
| 11/17/2021 | EYENOVIA, INC. | EYEN | Grant | Common Stock, par value $.0001 | 7k | $0.00 | $0 | | 11/17/2021 |
| 11/17/2021 | EYENOVIA, INC. | EYEN | Grant | Stock Option (right to buy) | 9.7k | $3.59 | $34.7k | | 11/17/2021 |
| 09/30/2021 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 549.265 | $0.00 | $0 | | 09/30/2021 |
| 06/13/2021 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 902 | $0.00 | $0 | | 06/13/2021 |
| 06/03/2021 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 2.9k | $0.00 | $0 | | 06/03/2021 |
| 03/31/2021 | EYENOVIA, INC. | EYEN | Grant | Common Stock, par value $.0001 | 1.2k | $0.00 | $0 | | 03/31/2021 |
| 03/31/2021 | EYENOVIA, INC. | EYEN | Grant | Stock Option (right to buy) | 1.6k | $5.11 | $8.4k | | 03/31/2021 |
| 02/01/2021 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 3.1k | $62.21 | $190k | | 02/01/2021 |
| 12/31/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 523.94 | $62.03 | $32.5k | | 12/31/2020 |
| 09/30/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 539.061 | $60.29 | $32.5k | | 09/30/2020 |
| 06/30/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 528.893 | $58.80 | $31.1k | | 06/30/2020 |
| 06/14/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 558 | $0.00 | $0 | | 06/13/2020 |
| 06/13/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 903 | $0.00 | $0 | | 06/13/2020 |
| 06/03/2020 | BRISTOL MYERS SQUIBB CO | BMY | Exercise | Restricted Stock Units | 2.9k | $0.00 | $0 | | 06/03/2020 |
| 03/31/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 515.788 | $55.74 | $28.8k | | 03/31/2020 |
| 02/01/2020 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 3k | $62.95 | $190k | | 02/01/2020 |
| 12/31/2019 | BRISTOL MYERS SQUIBB CO | BMY | Grant | Deferred Share Units | 177.802 | $64.19 | $11.4k | | 12/31/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Common Stock | 2.4k | $0.00 | $0 | | 11/20/2019 |
| 11/20/2019 | CELGENE CORP /DE/ | CELG | Disposition | Stock Option (right to buy) | 10k | $117.53 | $1.2M | | 11/20/2019 |
|